Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

49.18
BATS BZX Real-Time Price
As of 10:24am ET
 +0.61 / +1.26%
Today’s Change
36.76
Today|||52-Week Range
49.30
+28.04%
Year-to-Date

Today’s Trading

Previous close48.57
Today’s open48.76
Day’s range48.54 - 49.27
Volume101,276
Average volume (3 months)6,982,581
Market cap$84.3B
Dividend yield2.16%
Data as of 10:24am ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+12.45%
Earnings growth (next 5 years)+10.95%
Revenue growth (last year)+2.20%
P/E ratio55.3
Price/Sales2.73
Price/Book3.48

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.02+0.05%
AGNAllergan+2.37+0.97%
AZNAstraZeneca+0.53+1.52%
LLYEli Lilly and Co+1.34+1.62%
Data as of 10:24am ET, 06/22/2017

Financials

Next reporting dateJuly 19, 2017
EPS forecast (this quarter)$0.61
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts